Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 166

1.

Eplerenone is not superior to older and less expensive aldosterone antagonists.

Chatterjee S, Moeller C, Shah N, Bolorunduro O, Lichstein E, Moskovits N, Mukherjee D.

Am J Med. 2012 Aug;125(8):817-25. doi: 10.1016/j.amjmed.2011.12.018. Review.

PMID:
22840667
[PubMed - indexed for MEDLINE]
2.

A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.

McKenna C, Burch J, Suekarran S, Walker S, Bakhai A, Witte K, Harden M, Wright K, Woolacott N, Lorgelly P, Fenwick L, Palmer S.

Health Technol Assess. 2010 May;14(24):1-162. doi: 10.3310/hta14240. Review.

PMID:
20492762
[PubMed - indexed for MEDLINE]
Free Article
3.

Cost-effectiveness analysis of aldosterone blockade with eplerenone in patients with heart failure after acute myocardial infarction in the French context: the EPHESUS study.

de Pouvourville G, Solesse A, Beillat M.

Arch Cardiovasc Dis. 2008 Sep;101(9):515-21. doi: 10.1016/j.acvd.2008.09.001. Epub 2008 Nov 6.

PMID:
19041835
[PubMed - indexed for MEDLINE]
Free Article
4.

Cost effectiveness of eplerenone in patients with heart failure after acute myocardial infarction who were taking both ACE inhibitors and beta-blockers: subanalysis of the EPHESUS.

Zhang Z, Mahoney EM, Kolm P, Spertus J, Caro J, Willke R, Weintraub WS.

Am J Cardiovasc Drugs. 2010;10(1):55-63. doi: 10.2165/11319940-000000000-00000.

PMID:
20104935
[PubMed - indexed for MEDLINE]
5.

Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.

Moore TD, Nawarskas JJ, Anderson JR.

Heart Dis. 2003 Sep-Oct;5(5):354-63. Review.

PMID:
14503934
[PubMed - indexed for MEDLINE]
6.

Eplerenone: a selective aldosterone receptor antagonist for patients with heart failure.

Barnes BJ, Howard PA.

Ann Pharmacother. 2005 Jan;39(1):68-76. Epub 2004 Dec 8. Review. Erratum in: Ann Pharmacother. 2005 May;39(5):978.

PMID:
15590870
[PubMed - indexed for MEDLINE]
7.

Additional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: a systematic review and meta-analysis.

Hu LJ, Chen YQ, Deng SB, Du JL, She Q.

Br J Clin Pharmacol. 2013 May;75(5):1202-12. doi: 10.1111/bcp.12012. Review.

PMID:
23088367
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M; Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators.

N Engl J Med. 2003 Apr 3;348(14):1309-21. Epub 2003 Mar 31. Erratum in: N Engl J Med. 2003 May 29;348(22):2271.

PMID:
12668699
[PubMed - indexed for MEDLINE]
Free Article
9.

Ethics and eplerenone.

Gupta S, Fugh-Berman AJ, Scialli A.

J Med Ethics. 2013 Feb;39(2):110-4. doi: 10.1136/medethics-2011-100258. Epub 2012 Sep 26.

PMID:
23015747
[PubMed - indexed for MEDLINE]
10.

Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure.

Weintraub WS, Zhang Z, Mahoney EM, Kolm P, Spertus JA, Caro J, Ishak J, Goldberg R, Tooley J, Willke R, Pitt B.

Circulation. 2005 Mar 8;111(9):1106-13. Epub 2005 Feb 21.

PMID:
15723981
[PubMed - indexed for MEDLINE]
Free Article
11.

Eplerenone in the treatment of chronic heart failure.

Krum H, Liew D.

Expert Rev Cardiovasc Ther. 2004 May;2(3):315-20. Review.

PMID:
15151479
[PubMed - indexed for MEDLINE]
12.

Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study.

Krum H, Shi H, Pitt B, McMurray J, Swedberg K, van Veldhuisen DJ, Vincent J, Pocock S, Zannad F; EMPHASIS-HF Study Group.

Circ Heart Fail. 2013 Jul;6(4):711-8. doi: 10.1161/CIRCHEARTFAILURE.112.000173. Epub 2013 Apr 26.

PMID:
23625945
[PubMed - indexed for MEDLINE]
Free Article
13.

Eplerenone : a pharmacoeconomic review of its use in patients with post-myocardial infarction heart failure.

Croom KF, Plosker GL.

Pharmacoeconomics. 2005;23(10):1057-72. Review.

PMID:
16235978
[PubMed - indexed for MEDLINE]
14.

Adherence to aldosterone-blocking agents in patients with heart failure.

Margolis J, Gerber RA, Roberts C, Gheorghiade M.

Am J Ther. 2010 Sep-Oct;17(5):446-54. doi: 10.1097/MJT.0b013e3181ea3213.

PMID:
20844344
[PubMed - indexed for MEDLINE]
15.

Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS.

O'Keefe JH, Abuissa H, Pitt B.

Diabetes Obes Metab. 2008 Jun;10(6):492-7. Epub 2007 May 8.

PMID:
17490427
[PubMed - indexed for MEDLINE]
16.

Eplerenone in patients with systolic heart failure and mild symptoms.

Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B; EMPHASIS-HF Study Group.

N Engl J Med. 2011 Jan 6;364(1):11-21. doi: 10.1056/NEJMoa1009492. Epub 2010 Nov 14.

PMID:
21073363
[PubMed - indexed for MEDLINE]
Free Article
17.

Eplerenone: selective aldosterone antagonism in management of cardiovascular and renal disease.

Brennan BJ, Martin NE.

J Am Pharm Assoc (2003). 2004 Sep-Oct;44(5):604-10; quiz 610-1. Review.

PMID:
15496047
[PubMed - indexed for MEDLINE]
18.

New treatment option for heart failure patients: eplerenone.

Southworth MR, Cavallari LH.

J Cardiovasc Nurs. 2004 Nov-Dec;19(6):390-5. Review.

PMID:
15529060
[PubMed - indexed for MEDLINE]
19.

Drug insight: aldosterone-receptor antagonists in heart failure--the journey continues.

Kalidindi SR, Tang WH, Francis GS.

Nat Clin Pract Cardiovasc Med. 2007 Jul;4(7):368-78. Review.

PMID:
17589427
[PubMed - indexed for MEDLINE]
20.

Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study.

Rossignol P, Cleland JG, Bhandari S, Tala S, Gustafsson F, Fay R, Lamiral Z, Dobre D, Pitt B, Zannad F.

Circulation. 2012 Jan 17;125(2):271-9. doi: 10.1161/CIRCULATIONAHA.111.028282. Epub 2011 Nov 29.

PMID:
22128223
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk